Accounting for incomplete testing in the estimation of epidemic parameters
暂无分享,去创建一个
[1] S. Bhatt,et al. Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries , 2020 .
[2] E B Wilson,et al. The Epidemic Curve. , 1942, Proceedings of the National Academy of Sciences of the United States of America.
[3] Qiurong Ruan,et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.
[4] Rick Nunes-Vaz,et al. Visualising the doubling time of COVID-19 allows comparison of the success of containment measures , 2020 .
[5] M. Dhenain. ESTIMATION OF COVID-19 CASES IN FRANCE AND IN DIFFERENT COUNTRIES: HOMOGENEISATION BASED ON MORTALITY , 2020, medRxiv.
[6] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[7] Xiaolong Qi,et al. Real estimates of mortality following COVID-19 infection , 2020, The Lancet Infectious Diseases.
[8] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[9] Fei Zhou. Clinical Course And Risk Factors For Mortality Of Adult In Patients With COVID-19 In Wuhan, China: A Retrospective Cohort Study , 2020 .